Review of Pharmacotherapy in Multiple Sclerosis - July 26, 2023
Mary Greeley Medical Center via YouTube
Overview
Syllabus
Intro
Objectives
Goal of Disease Modifying Therapy (DMT)
Factors that impact patient's DMT choice
Interferons
Glatiramer acetate
Monomethyl Fumarate Pro-Drugs
Sphingosine 1 Phosphate Receptor Modulators
Teriflunomide (Aubagio®)
Cladribine (MavencladⓇ)
Natalizumab (Tysabri®)
Ocrelizumab (Ocrevus®)
Ofatumumab (Kesimpta®)
Alemtuzumab (Lemtrada®)
Inpatient admission
Infections and Vaccination
Malignancy
Summary
Taught by
Mary Greeley Medical Center